IMI/REL (MK-7655A) vs. PIP/TAZ in Treatment of Subjects with HABP/VABP

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-000246-34

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the incidence rate of all-cause mortality through Day 28 post-randomization associated with treatment with IMI/REL compared to treatment with PIP/TAZ in subjects diagnosed with HABP/VABP in the modified intention-to-treat (MITT) population.


Critère d'inclusion

  • Treatment for hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP)